Case Report: An ovarian epithelial-type serous adenocarcinoma of the testis was treated using systemic chemotherapy with bevacizumab, the treatment strategy used for ovarian serous carcinoma
Ovarian-type serous adenocarcinoma of the testis is an extremely rare malignant disease, and experience and evidence regarding its treatment are lacking. Herein, we describe the case of a 39-year-old man who presented with widespread metastasis in the retroperitoneal and pelvic lymph nodes after sur...
Saved in:
| Main Authors: | Rui-Zhi Liu, Shuang Zhang, Jing Gong, Jin Yao, Hao Zeng, Lang He |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-03-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1467579/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serous borderline ovarian tumors (clinical features, morphology, treatment)
by: I. Yu. Davydova, et al.
Published: (2014-07-01) -
Bevacizumab in ovarian cancer therapy: current advances, clinical challenges, and emerging strategies
by: Mingyue Zhang, et al.
Published: (2025-05-01) -
IMMUNOHISTROCHEMISTRY AND FLOW CYTOMETRIC CHARACTERISTICS OF INTRATUMORAL LYMPHOCYTES IN OVARIAN SEROUS ADENOCARCINOMA
by: E. V. Zuyeva, et al.
Published: (2014-09-01) -
Clinical case use bevacizumab for patient with metastatic ovarian cancer
by: M. R. Oganyan, et al.
Published: (2014-07-01) -
Efficacy and safety analyses of bevacizumab in neoadjuvant chemotherapy for ovarian cancer: a systematic review and meta-analysis
by: Yijun Wang, et al.
Published: (2025-05-01)